| The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study M Di Forti, D Quattrone, TP Freeman, G Tripoli, C Gayer-Anderson, ... The Lancet Psychiatry 6 (5), 427-436, 2019 | 813 | 2019 |
| Standardized remission criteria in schizophrenia J van Os, T Burns, R Cavallaro, S Leucht, J Peuskens, L Helldin, ... Acta Psychiatrica Scandinavica 113 (2), 91-95, 2006 | 371 | 2006 |
| Assessment and management of agitation in psychiatry: expert consensus M Garriga, I Pacchiarotti, S Kasper, SL Zeller, MH Allen, G Vazquez, ... The world journal of biological psychiatry 17 (2), 86-128, 2016 | 368 | 2016 |
| Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia P Wright, M Birkett, SR David, K Meehan, I Ferchland, KJ Alaka, ... American Journal of Psychiatry 158 (7), 1149-1151, 2001 | 353 | 2001 |
| Metabolic profile of antipsychotic-naive individuals with non-affective psychosis E Fernandez-Egea, M Bernardo, T Donner, I Conget, E Parellada, ... The British journal of psychiatry 194 (5), 434-438, 2009 | 303 | 2009 |
| Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations European Network of National Networks studying Gene-Environment Interactions ... Schizophrenia bulletin 40 (4), 729-736, 2014 | 274 | 2014 |
| International trends in antipsychotic use: a study in 16 countries, 2005–2014 Ó Hálfdánarson, H Zoëga, L Aagaard, M Bernardo, L Brandt, AC Fusté, ... European Neuropsychopharmacology 27 (10), 1064-1076, 2017 | 262 | 2017 |
| Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease. AM Catafau, E Parellada, FJ Lomeña, M Bernardo, J Pavía, D Ros, ... Journal of nuclear medicine: official publication, Society of Nuclear …, 1994 | 261 | 1994 |
| Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study R Penadés, N Pujol, R Catalán, G Massana, G Rametti, C García-Rizo, ... Biological psychiatry 73 (10), 1015-1023, 2013 | 226 | 2013 |
| Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients P Salgado-Pineda, I Baeza, M Pérez-Gómez, P Vendrell, C Junqué, ... Neuroimage 19 (2), 365-375, 2003 | 218 | 2003 |
| Inflammation in schizophrenia: a question of balance JC Leza, B García-Bueno, M Bioque, C Arango, M Parellada, K Do, ... Neuroscience & Biobehavioral Reviews 55, 612-626, 2015 | 209 | 2015 |
| Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial V Pérez, A Salavert, J Espadaler, M Tuson, J Saiz-Ruiz, C Sáez-Navarro, ... BMC psychiatry 17, 1-13, 2017 | 207 | 2017 |
| Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia B García-Bueno, M Bioque, KS Mac-Dowell, MF Barcones, ... Schizophrenia bulletin 40 (2), 376-387, 2014 | 197 | 2014 |
| Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study RS Kahn, IW van Rossum, S Leucht, P McGuire, SW Lewis, M Leboyer, ... The Lancet Psychiatry 5 (10), 797-807, 2018 | 189 | 2018 |
| Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients P Salgado-Pineda, C Junqué, P Vendrell, I Baeza, N Bargalló, C Falcón, ... Neuroimage 21 (3), 840-847, 2004 | 150 | 2004 |
| Assessing clinical and functional outcomes in a gene–environment interaction study in first episode of psychosis (PEPs) M Bernardo, M Bioque, M Parellada, JS Ruiz, MJ Cuesta, A Llerena, ... Revista de Psiquiatría y Salud Mental (English Edition) 6 (1), 4-16, 2013 | 129 | 2013 |
| Cognitive mechanisms, psychosocial functioning, and neurocognitive rehabilitation in schizophrenia R Penadés, T Boget, R Catalán, M Bernardo, C Gastó, M Salamero Schizophrenia research 63 (3), 219-227, 2003 | 127 | 2003 |
| Regional cerebral blood flow pattern in normal young and aged volunteers: a99mTc-HMPAO SPET study AM Catafau, FJ Lomeña, J Pavia, E Parellada, M Bernardo, J Setoain, ... European journal of nuclear medicine 23, 1329-1337, 1996 | 124 | 1996 |
| Glucose abnormalities in the siblings of people with schizophrenia E Fernandez-Egea, M Bernardo, E Parellada, A Justicia, C Garcia-Rizo, ... Schizophrenia research 103 (1-3), 110-113, 2008 | 123 | 2008 |
| Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis E Fernandez-Egea, M Bernardo, CM Heaphy, JK Griffith, E Parellada, ... Schizophrenia bulletin 35 (2), 437-442, 2009 | 120 | 2009 |
